| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Primary Ovarian Insufficiency | 8 | 2015 | 72 | 1.880 |
Why?
|
| Infertility, Female | 2 | 2015 | 217 | 0.910 |
Why?
|
| Hyaluronic Acid | 3 | 2019 | 168 | 0.700 |
Why?
|
| Viscosupplements | 1 | 2019 | 10 | 0.680 |
Why?
|
| Intrauterine Devices | 1 | 2019 | 19 | 0.680 |
Why?
|
| Tissue Adhesions | 1 | 2019 | 60 | 0.660 |
Why?
|
| Ovarian Follicle | 2 | 2015 | 152 | 0.510 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2015 | 167 | 0.480 |
Why?
|
| Fragile X Syndrome | 1 | 2015 | 150 | 0.480 |
Why?
|
| Decidua | 6 | 2017 | 154 | 0.460 |
Why?
|
| Pregnancy | 19 | 2022 | 7573 | 0.450 |
Why?
|
| Hormone Replacement Therapy | 1 | 2015 | 205 | 0.440 |
Why?
|
| Spermatozoa | 6 | 2009 | 315 | 0.430 |
Why?
|
| Estrogens | 1 | 2015 | 751 | 0.380 |
Why?
|
| Stromal Cells | 6 | 2017 | 825 | 0.370 |
Why?
|
| Oligospermia | 4 | 2005 | 67 | 0.370 |
Why?
|
| Endometrium | 4 | 2019 | 470 | 0.360 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2007 | 650 | 0.300 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2022 | 5539 | 0.300 |
Why?
|
| Diploidy | 2 | 2005 | 114 | 0.300 |
Why?
|
| Oocytes | 1 | 2007 | 414 | 0.260 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2009 | 488 | 0.260 |
Why?
|
| Sperm Count | 2 | 2004 | 100 | 0.260 |
Why?
|
| Phenylmethylsulfonyl Fluoride | 1 | 2004 | 1 | 0.250 |
Why?
|
| Semen Preservation | 1 | 2004 | 17 | 0.250 |
Why?
|
| Uniparental Disomy | 2 | 2005 | 66 | 0.240 |
Why?
|
| Semen | 1 | 2004 | 90 | 0.240 |
Why?
|
| Blood Pressure | 1 | 2010 | 1467 | 0.230 |
Why?
|
| Progesterone | 3 | 2022 | 513 | 0.230 |
Why?
|
| Inosine Monophosphate | 1 | 2022 | 1 | 0.220 |
Why?
|
| Abortion, Spontaneous | 2 | 2014 | 112 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2015 | 4549 | 0.220 |
Why?
|
| Nuclear Receptor Coactivator 2 | 2 | 2014 | 210 | 0.210 |
Why?
|
| Multifactorial Inheritance | 1 | 2022 | 148 | 0.200 |
Why?
|
| Receptors, Progesterone | 3 | 2015 | 1392 | 0.190 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 2 | 2017 | 13 | 0.190 |
Why?
|
| Sperm Injections, Intracytoplasmic | 3 | 2005 | 42 | 0.180 |
Why?
|
| Chromatin | 1 | 2004 | 942 | 0.170 |
Why?
|
| Gels | 1 | 2019 | 105 | 0.170 |
Why?
|
| Hysteroscopy | 1 | 2019 | 51 | 0.160 |
Why?
|
| Leiomyoma | 2 | 2009 | 145 | 0.160 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2015 | 241 | 0.160 |
Why?
|
| Gestational Age | 5 | 2010 | 1069 | 0.150 |
Why?
|
| Female | 35 | 2022 | 141928 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2017 | 84 | 0.150 |
Why?
|
| Secondary Prevention | 1 | 2019 | 329 | 0.150 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2014 | 142 | 0.140 |
Why?
|
| Chromosome Aberrations | 1 | 2003 | 1960 | 0.140 |
Why?
|
| Down Syndrome | 4 | 1999 | 226 | 0.140 |
Why?
|
| ADAMTS Proteins | 1 | 2015 | 15 | 0.130 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2015 | 36 | 0.130 |
Why?
|
| Oocyte Donation | 1 | 2015 | 42 | 0.130 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2015 | 61 | 0.130 |
Why?
|
| Inhibins | 1 | 2015 | 128 | 0.130 |
Why?
|
| Interferon Regulatory Factors | 1 | 2015 | 76 | 0.130 |
Why?
|
| Embryo Implantation | 2 | 2013 | 278 | 0.120 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 3 | 1999 | 51 | 0.120 |
Why?
|
| ADAM Proteins | 1 | 2015 | 134 | 0.120 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2015 | 75 | 0.120 |
Why?
|
| Cell Differentiation | 3 | 2014 | 4078 | 0.120 |
Why?
|
| Adult | 22 | 2019 | 77950 | 0.120 |
Why?
|
| Humans | 41 | 2022 | 261506 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2006 | 6869 | 0.120 |
Why?
|
| Activin Receptors, Type I | 1 | 2013 | 50 | 0.120 |
Why?
|
| Ultrasonography | 3 | 2019 | 1863 | 0.120 |
Why?
|
| Mass Screening | 1 | 2022 | 1509 | 0.120 |
Why?
|
| Phosphofructokinase-2 | 1 | 2013 | 38 | 0.120 |
Why?
|
| Infertility | 1 | 2015 | 123 | 0.120 |
Why?
|
| Genome-Wide Association Study | 3 | 2022 | 2265 | 0.110 |
Why?
|
| Embryo, Mammalian | 3 | 2022 | 741 | 0.110 |
Why?
|
| Endometriosis | 2 | 2014 | 214 | 0.110 |
Why?
|
| Osteoporosis | 1 | 2015 | 241 | 0.110 |
Why?
|
| Uterus | 2 | 2014 | 678 | 0.110 |
Why?
|
| Fertilization in Vitro | 2 | 2004 | 199 | 0.100 |
Why?
|
| Fertility | 1 | 2014 | 336 | 0.100 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2012 | 236 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2022 | 2803 | 0.100 |
Why?
|
| Estriol | 3 | 1999 | 9 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2014 | 2508 | 0.090 |
Why?
|
| Bone Morphogenetic Protein 15 | 2 | 2007 | 42 | 0.090 |
Why?
|
| Growth Differentiation Factor 9 | 2 | 2007 | 47 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 622 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 778 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 3154 | 0.090 |
Why?
|
| Relaxin | 1 | 2009 | 21 | 0.090 |
Why?
|
| Mexico | 1 | 2010 | 259 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 526 | 0.090 |
Why?
|
| RNA, Small Interfering | 4 | 2017 | 2216 | 0.080 |
Why?
|
| Gene Expression | 2 | 2010 | 3570 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 591 | 0.080 |
Why?
|
| Sex Determination Processes | 1 | 2007 | 17 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2015 | 2203 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2017 | 7226 | 0.080 |
Why?
|
| alpha-Fetoproteins | 2 | 1998 | 237 | 0.070 |
Why?
|
| Biomarkers | 3 | 2015 | 5047 | 0.070 |
Why?
|
| DNA Mutational Analysis | 3 | 2007 | 2283 | 0.070 |
Why?
|
| X Chromosome | 1 | 2007 | 339 | 0.070 |
Why?
|
| Neck | 2 | 1999 | 383 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2009 | 829 | 0.070 |
Why?
|
| Chromosome Deletion | 1 | 2011 | 1005 | 0.070 |
Why?
|
| Prenatal Diagnosis | 3 | 1999 | 590 | 0.070 |
Why?
|
| Pregnancy Rate | 2 | 2022 | 58 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2014 | 2295 | 0.070 |
Why?
|
| Embryo Transfer | 2 | 2022 | 83 | 0.070 |
Why?
|
| Sperm Maturation | 2 | 2009 | 10 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 3 | 1999 | 830 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2006 | 445 | 0.070 |
Why?
|
| Uterine Perforation | 1 | 2004 | 6 | 0.060 |
Why?
|
| Hysterosalpingography | 1 | 2004 | 15 | 0.060 |
Why?
|
| Uterine Neoplasms | 1 | 2009 | 545 | 0.060 |
Why?
|
| Aneuploidy | 1 | 2005 | 369 | 0.060 |
Why?
|
| Anemia | 2 | 2000 | 689 | 0.060 |
Why?
|
| Granulosa Cells | 1 | 2004 | 146 | 0.060 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2003 | 50 | 0.060 |
Why?
|
| Chromosomes, Human, Y | 1 | 2003 | 53 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 518 | 0.060 |
Why?
|
| DNA Probes | 1 | 2003 | 217 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2004 | 210 | 0.060 |
Why?
|
| Mutation | 3 | 2007 | 15179 | 0.060 |
Why?
|
| Dydrogesterone | 1 | 2022 | 1 | 0.060 |
Why?
|
| Obesity | 1 | 2015 | 2884 | 0.050 |
Why?
|
| Chromosomes, Human, X | 1 | 2003 | 192 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2004 | 652 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 1143 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 161 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2005 | 2232 | 0.050 |
Why?
|
| Infertility, Male | 1 | 2004 | 297 | 0.050 |
Why?
|
| Prognosis | 3 | 2015 | 21713 | 0.050 |
Why?
|
| Research Design | 1 | 2009 | 1544 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 984 | 0.050 |
Why?
|
| Disease Progression | 1 | 2012 | 6682 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2002 | 264 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2009 | 2086 | 0.050 |
Why?
|
| Rh Isoimmunization | 1 | 2000 | 15 | 0.050 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2000 | 63 | 0.050 |
Why?
|
| Attention | 1 | 2022 | 281 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2003 | 641 | 0.050 |
Why?
|
| Middle Cerebral Artery | 1 | 2000 | 85 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 4053 | 0.040 |
Why?
|
| Pregnancy Outcome | 2 | 2004 | 643 | 0.040 |
Why?
|
| Mice | 7 | 2014 | 34495 | 0.040 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 1999 | 24 | 0.040 |
Why?
|
| Umbilical Arteries | 1 | 1999 | 59 | 0.040 |
Why?
|
| Humerus | 1 | 1998 | 53 | 0.040 |
Why?
|
| Prevalence | 1 | 2006 | 3260 | 0.040 |
Why?
|
| Cerebral Arteries | 1 | 1999 | 73 | 0.040 |
Why?
|
| Chorionic Gonadotropin | 1 | 1998 | 130 | 0.040 |
Why?
|
| False Positive Reactions | 4 | 2000 | 355 | 0.040 |
Why?
|
| ROC Curve | 4 | 2004 | 1183 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2006 | 1589 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 4 | 1999 | 168 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2003 | 2316 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 2 | 2017 | 1130 | 0.040 |
Why?
|
| Young Adult | 3 | 2013 | 21445 | 0.040 |
Why?
|
| Signal Transduction | 5 | 2014 | 11965 | 0.040 |
Why?
|
| Fetal Growth Retardation | 1 | 1999 | 194 | 0.040 |
Why?
|
| Male | 9 | 2010 | 123000 | 0.040 |
Why?
|
| Animals | 8 | 2014 | 59536 | 0.040 |
Why?
|
| Arteries | 1 | 1999 | 274 | 0.040 |
Why?
|
| Risk Factors | 5 | 2007 | 17523 | 0.040 |
Why?
|
| Immunization | 1 | 1999 | 397 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 2000 | 388 | 0.040 |
Why?
|
| Spleen | 1 | 1999 | 676 | 0.040 |
Why?
|
| Sperm Motility | 2 | 2009 | 106 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 6942 | 0.030 |
Why?
|
| DNA | 1 | 2004 | 2693 | 0.030 |
Why?
|
| Transcriptome | 2 | 2015 | 1859 | 0.030 |
Why?
|
| Fetal Blood | 1 | 1999 | 482 | 0.030 |
Why?
|
| Pre-Eclampsia | 1 | 1998 | 212 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2015 | 5637 | 0.030 |
Why?
|
| Fos-Related Antigen-2 | 1 | 2015 | 7 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2015 | 29 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2015 | 62 | 0.030 |
Why?
|
| Amniocentesis | 3 | 1999 | 76 | 0.030 |
Why?
|
| Wnt4 Protein | 1 | 2014 | 31 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2012 | 3536 | 0.030 |
Why?
|
| Immunoassay | 1 | 2015 | 216 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 167 | 0.030 |
Why?
|
| Genome, Human | 2 | 2015 | 1869 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1077 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2014 | 110 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 246 | 0.030 |
Why?
|
| Maternal Age | 3 | 1999 | 152 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2014 | 5710 | 0.030 |
Why?
|
| Receptor, ErbB-3 | 1 | 2014 | 122 | 0.030 |
Why?
|
| Activins | 1 | 2013 | 98 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2013 | 62 | 0.030 |
Why?
|
| Incidence | 1 | 2003 | 5673 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 634 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1998 | 1271 | 0.030 |
Why?
|
| Reference Values | 3 | 1999 | 1099 | 0.030 |
Why?
|
| Choristoma | 1 | 2012 | 85 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2012 | 629 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2012 | 256 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 651 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 360 | 0.020 |
Why?
|
| Phenotype | 1 | 2022 | 6295 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2022 | 37905 | 0.020 |
Why?
|
| Algorithms | 2 | 1999 | 3890 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 2171 | 0.020 |
Why?
|
| Sensitivity and Specificity | 4 | 2000 | 4971 | 0.020 |
Why?
|
| Time Factors | 1 | 2004 | 12926 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 671 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 842 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 1408 | 0.020 |
Why?
|
| Cell Movement | 1 | 2017 | 2466 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 4314 | 0.020 |
Why?
|
| Desmin | 1 | 2009 | 63 | 0.020 |
Why?
|
| United States | 1 | 2006 | 15433 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2011 | 6100 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2009 | 47 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2009 | 71 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 2009 | 86 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2009 | 89 | 0.020 |
Why?
|
| Cytological Techniques | 1 | 2009 | 74 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 1265 | 0.020 |
Why?
|
| Base Sequence | 1 | 2015 | 4917 | 0.020 |
Why?
|
| Cytokines | 1 | 2017 | 2809 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 3438 | 0.020 |
Why?
|
| Caveolin 1 | 1 | 2009 | 204 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 549 | 0.020 |
Why?
|
| Mice, Inbred AKR | 1 | 2007 | 51 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 1439 | 0.020 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2007 | 95 | 0.020 |
Why?
|
| Software | 1 | 2015 | 1321 | 0.020 |
Why?
|
| Quality Control | 1 | 2009 | 457 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 6089 | 0.020 |
Why?
|
| High Mobility Group Proteins | 1 | 2007 | 59 | 0.020 |
Why?
|
| Y Chromosome | 1 | 2007 | 77 | 0.020 |
Why?
|
| Threonine | 1 | 2007 | 161 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 1538 | 0.020 |
Why?
|
| Alanine | 1 | 2007 | 240 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2012 | 973 | 0.020 |
Why?
|
| SOX9 Transcription Factor | 1 | 2007 | 170 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2007 | 343 | 0.020 |
Why?
|
| Introns | 1 | 2007 | 432 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 5377 | 0.020 |
Why?
|
| Andrology | 1 | 2005 | 11 | 0.020 |
Why?
|
| Forecasting | 2 | 1999 | 694 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 644 | 0.020 |
Why?
|
| Hyaluronan Synthases | 1 | 2004 | 20 | 0.020 |
Why?
|
| Fetus | 2 | 1999 | 601 | 0.020 |
Why?
|
| Serum Amyloid P-Component | 1 | 2004 | 32 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 6009 | 0.020 |
Why?
|
| Receptor, ErbB-2 | 1 | 2014 | 2518 | 0.020 |
Why?
|
| Ovulation Induction | 1 | 2004 | 62 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2007 | 1163 | 0.020 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 104 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 215 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2004 | 4892 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2013 | 6150 | 0.010 |
Why?
|
| Transcription Factors | 2 | 2007 | 5270 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 3203 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 1618 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 483 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2011 | 2291 | 0.010 |
Why?
|
| Logistic Models | 2 | 1999 | 3441 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2002 | 409 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2009 | 1664 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2004 | 527 | 0.010 |
Why?
|
| Cordocentesis | 1 | 2000 | 5 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2009 | 4804 | 0.010 |
Why?
|
| Heart Rate, Fetal | 1 | 2000 | 51 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 14889 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 6086 | 0.010 |
Why?
|
| Cellular Senescence | 1 | 2002 | 382 | 0.010 |
Why?
|
| Adolescent | 2 | 2013 | 31252 | 0.010 |
Why?
|
| Image Cytometry | 1 | 1999 | 47 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1999 | 92 | 0.010 |
Why?
|
| Prospective Studies | 3 | 1999 | 12873 | 0.010 |
Why?
|
| Middle Aged | 3 | 2013 | 86204 | 0.010 |
Why?
|
| Wound Healing | 1 | 2004 | 815 | 0.010 |
Why?
|
| Rheology | 1 | 1999 | 55 | 0.010 |
Why?
|
| Ultrasonics | 1 | 1999 | 69 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2004 | 8223 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 1999 | 131 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1998 | 204 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 7548 | 0.010 |
Why?
|
| Morbidity | 1 | 1999 | 397 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 3343 | 0.010 |
Why?
|
| Karyotyping | 1 | 1999 | 1022 | 0.010 |
Why?
|
| Birth Weight | 1 | 1999 | 374 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1999 | 614 | 0.010 |
Why?
|
| Biometry | 1 | 1998 | 241 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1999 | 477 | 0.010 |
Why?
|
| Creatinine | 1 | 1998 | 531 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 4821 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2004 | 1225 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 2819 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 14551 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2002 | 9244 | 0.010 |
Why?
|
| Aged | 1 | 2009 | 70117 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2002 | 32848 | 0.000 |
Why?
|